P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: A potential diagnostic problem

Virchows Archiv

Volumn 445, Issue 6, 2004, Pages 610-615

  Murphy, N ^a,b   Heffron, C C B B ^a   King, B ^a   Ganuguapati, U G ^a   Ring, M ^a,b   McGuinness, E ^b   Sheils, O ^b   O'Leary, J J ^a,b  

^a Pathology Research Laboratory   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adenocarcinoma in situ; Cervical glandular intraepithelial neoplasia; p16INK4A

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16INK4A;

ADENOCARCINOMA; ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA; STAINING; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; CHEMISTRY; ENDOMETRIUM; METAPLASIA; PATHOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 12144251609     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1111-4     Document Type: Article

References (46)

1. Anderson G, Gordon KC (1996) Tissue processing, microtomy and paraffin sections. In: Bancroft JD, Stevens A (eds) Theory and practice of histological techniques, 4th edn. Churchill & Livingstone, New York
2. Brown LJ, Wells M (1986) Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 39:22-28
3. INK4A assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 41:313-321
4. Cina SJ, Richardson MS (1997) Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 10:176-180
5. Ducatman BS, Wang HH (1993) Tubal metaplasia: a cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix. Diagn Cytopathol 9:98-103
6. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Volck DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J et al (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A 89:10557
7. Friedell G, McKay D (1953) Adenocarcinoma in situ of the endocervix. Cancer 6:887-897
8. Goldstein NS, Ahmad E (1998) Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 110:200-209
9. Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A (2001) Loss of expression of the p16 tumour suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations. Gynecol Oncol 83:491-500
10. Healy E, Rehman I, Angus B, Rees JL (1995) Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer 12:152
11. Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912-917
12. Johnson JE, Rahemtulla A (1999) Endocervical glandular neoplasia and its mimics in ThinPrep Pap tests. A descriptive study. Acta Cytol 43:369-375
13. Jonasson JG, Wang HH (1992) Tubal metaplasia of the uterine cervix: a prevalence study in patients with gynaecological pathologic findings. Int J Gynecol Pathol 11: 89-95
14. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:22
15. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP (2001) Ki-67, Cyclin E, and p16 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25:884-891
16. Klaes R, Friedrich T (2001) Overexpression of p16 as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276-284
17. Krane JF, Granter SR (2001) Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 93:8-15
18. Kudoh K, Ichikawa Y, Yoshida S, Hirai M, Kikuchi Y, Nagata I, Miwa M, Uchida K (2002) Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Int J Cancer 99:579-582
19. Liao SY, Brewer C (1994) Identification of MN antigen as a marker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am J Pathol 145:598-609
20. Marques T, Andrade LA (1997) Endocervical tubal metaplasia: morphological concepts and practical importance. Rev Assoc Med Bras 43:21-24
21. McCluggage WG (2002) Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 40:309-326
22. McCluggage WG (2003) Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol 56:164-173
23. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H (1995) Monoclonal antibodies Ki67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 14:209-216
24. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, McGuinness E, Griffin, Martin C, Sheils O, O'Leary JJ (2003) P16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56:56-63
25. Negri G, Egarter-Vigl E, Kasal A, Roman F, Haitel A, Mian C (2003) p16INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol 27:187-193
26. Nielsen GP, Stemmer-Rachaminov AO (1999) Immunohistochemical survey of p16 expression in normal human adult and infant tissues. Lab Invest 79:1137-1141
27. Novotny DB, Maygarden S (1992) Tubal metaplasia - a frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 36:1-10
28. Olivia E, Clement PB (1995) Tubal and tubo-endometrioid metaplasia of the uterine cervix. Unemphasized features that may cause problems in differential diagnosis: a report of 25 cases. Am J Clin Pathol 103:618-623
29. Pacey F, Ayer B, Greenberg M (1988) The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis. Acta Cytol 32:325-330
30. Riethdorf L, O'Connell JT (2000) Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri. Virchows Arch 437:365-371
31. Riethdorf L, Riethdorf S (2002) Human papillomaviruses, expression of p16 and early endocervical glandular neoplasia. Hum Pathol 33:899-904
32. Saegusa M, Machida BD, Okayasu I (2001) Possible associations among expression of p14 (ARF), p16 (INK4A), p21 (WAF1/CIP1), p27 (KIP1) and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer 92:1177-1189
33. Saigo PE, Wolinska WH (1985) The role of cytology in the diagnosis and follow up of patients with cervical adenocarcinoma. Acta Cytol 29:785-794
34. Sano T, Oyama T (1998) Expression status of p16 protein is associated with human papilloma virus oncogenic potential in cervical and genital lesions. Am J Pathol 153:1741-1748
35. Schwartz S, Weiss N (1986) Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 124:1045-1047
36. Segal GH, Hart WR (1990) Cystic endocervical tunnel clusters: a clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am J Surg Pathol 14:895-903
37. Selvaggi SM, Haefner HK (1997) Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Diagn Cytopathol 16:168-173
38. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumour suppression and cell mortality Cell 85:27
39. Suh KS, Silverberg SG (1990) Tubal metaplasia of the uterine cervix. Int J Gynecol Pathol 9:122-128
40. Umezaki K, Sanezumi M (1998) Immunohistochemical demonstration of aberrant glycosylation and epidermal growth factor receptor in tubal metaplasia of the uterine cervix. Gynecol Oncol 70:40-44
41. Von Knebel Doeberitz M (2001) New molecular tools for efficient screening of cervical cancer. Dis Markers 17:123-128
42. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, Marr J, Laskey RA, Coleman N (1998) Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 95:14932-14937
43. Wong YF, Chung TK (1999) Methylation of p16 in primary gynaecologic malignancy. Cancer Lett 136:231-235
44. Yoshinouchi M, Hongo A (2000) Alteration of the CDKN2/P16 gene is not required for HPV-positive uterine cervical cell lines. Int J Oncol 16:537-541
45. Young RH, Scully RE (1989) Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma: a report of 5 cases and a review of the literature. Am J Surg Pathol 13:50-56
46. Zaino RJ (2000) Glandular lesions of the uterine cervix. Mod Pathol 13:261-274